I will do pharma conference coverage, market intelligence and business intelligence

Comprehensive commercial evaluation of a pharmaceutical molecule or asset, including market size, patient population, standard of care (SoC), competitive clinical benefit, pipeline landscape, market uptake potential, revenue opportunity, pricing & reimbursement considerations, and strategic commercial recommendations to support licensing, investment, or launch decisions.